A groundbreaking milestone has been reached in the fight against malaria. Novartis announced today that its revolutionary treatment has received official approval to combat malaria in newborns and infants, signaling a major advancement in global health. This groundbreaking pharmaceutical will now be available in countries where malaria is most pre